PLEKHG4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 5.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
5.464000E-01
Normal-vs-Stage2
6.285200E-01
Normal-vs-Stage3
2.261200E-01
Normal-vs-Stage4
8.680800E-01
Stage1-vs-Stage2
8.883200E-01
Stage1-vs-Stage3
7.450000E-02
Stage1-vs-Stage4
5.524600E-01
Stage2-vs-Stage3
2.202100E-04
Stage2-vs-Stage4
7.191400E-01
Stage3-vs-Stage4
1.727730E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
3.940400E-01
Normal-vs-AfricanAmerican
5.853200E-01
Normal-vs-Asian
7.913600E-01
Caucasian-vs-AfricanAmerican
3.113400E-01
Caucasian-vs-Asian
3.267200E-01
AfricanAmerican-vs-Asian
3.881800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
4.767000E-01
Normal-vs-Female
6.502600E-01
Male-vs-Female
9.660800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
5.421200E-01
Normal-vs-Age(41-60Yrs)
2.153000E-01
Normal-vs-Age(61-80Yrs)
7.223800E-01
Normal-vs-Age(81-100Yrs)
4.516400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.915200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.104400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.810800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.302760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.693800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.600400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
1.919380E-01
Normal-vs-Daily Drinker
9.763000E-01
Normal-vs-Weekly Drinker
8.348200E-01
Normal-vs-Occasional Drinker
7.779200E-01
Normal-vs-Social Drinker
4.216200E-01
Non Drinker-vs-Daily Drinker
2.149400E-01
Non Drinker-vs-Weekly Drinker
2.236000E-01
Non Drinker-vs-Occasional Drinker
1.065020E-01
Non Drinker-vs-Social Drinker
5.706200E-01
Daily Drinker-vs-Weekly Drinker
7.291600E-01
Daily Drinker-vs-Occasional Drinker
6.776600E-01
Daily Drinker-vs-Social Drinker
1.466230E-01
Weekly Drinker-vs-Occasional Drinker
9.510800E-01
Weekly Drinker-vs-Social Drinker
1.322020E-01
Occasional Drinker-vs-Social Drinker
6.942200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
2.674600E-01
Normal-vs-Grade 2
3.450800E-01
Normal-vs-Grade 3
2.182600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.286000E-01
Grade 1-vs-Grade 3
3.090400E-01
Grade 1-vs-Grade 4
2.674600E-01
Grade 2-vs-Grade 3
7.466400E-01
Grade 2-vs-Grade 4
3.450800E-01
Grade 3-vs-Grade 4
2.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
5.028000E-01
Normal-vs-NonDiabetic
6.048800E-01
Diabetic-vs-NonDiabetic
7.786000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
9.227800E-01
Normal-vs-NoPancreatitis
3.764000E-01
Pancreatitis-vs-NoPancreatitis
4.916800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
3.514800E-01
Normal-vs-N1
6.110800E-01
N0-vs-N1
4.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
9.398800E-01
Normal-vs-TP53-NonMutant
7.694000E-01
TP53-Mutant-vs-TP53-NonMutant
6.711800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap